CAS 1853164-83-6

IPN60090

CAS : 1853164-83-6

IPN60090

Degré de pureté : ≥98%

Masse moléculaire : 532.52g/mol

Ref: 54-BUP09340

IPN-60090

CAS : 1853164-83-6

IPN-60090 is an analog of an anticancer kinase inhibitor that has shown promising results in the treatment of various types of cancer. It is a potent inhibitor of kinases that are involved in tumor cell proliferation and survival. IPN-60090 has been tested on Chinese hamster ovary cells and human urine-derived cancer cells, where it was found to induce apoptosis (programmed cell death) and inhibit the growth of cancer cells. This protein kinase inhibitor has shown excellent anticancer activity against a range of tumors, making it a promising candidate for the development of new cancer therapies. Additionally, IPN-60090 has been shown to have low toxicity and good safety profiles, making it an attractive option for further clinical development.

Formule : C₂₄H₂₇F₃N₈O₃

Degré de pureté : Min. 95%

Masse moléculaire : 532.5 g/mol

Ref: 3D-DZC16483

IPN60090

CAS : 1853164-83-6

IPN60090: potent oral GLS1 inhibitor, IC50 of 31 nM, potential for anticancer and immunomodulation.

Formule : C₂₄H₂₇F₃N₈O₃

Degré de pureté : 99.76%

Couleur et forme : Solid

Masse moléculaire : 532.52

Ref: TM-T11412